Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.


  1. Advanced Patent Search
Publication numberUS3862302 A
Publication typeGrant
Publication dateJan 21, 1975
Filing dateOct 4, 1971
Priority dateMar 20, 1969
Also published asDE2013498A1, US3655838
Publication numberUS 3862302 A, US 3862302A, US-A-3862302, US3862302 A, US3862302A
InventorsRichard Thompson Price, Stuart Michael Bauer, John Brownlee, Bastiaan Cornelis Goverde
Original AssigneeAkzona Inc
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Pelletized pregnancy test reagents
US 3862302 A
Abstract  available in
Previous page
Next page
Claims  available in
Description  (OCR text may contain errors)

atent 1 Price et al.

1 1 PELLETIZED PREGNANCY TEST REAGENTS [75] Inventors: Richard Thompson Price, Verona; Stuart Michael Bauer, Parsippany, both of N.J.; John Brownlee, West Seneca, N.Y.; Bastiaan Cornelis Goverde, Oss, Netherlands [73] Assignee: Akzona Incorporated, Asheville,

[22] Filed: Oct. 4, 1971 [21] Appl. No.: 186,473

Related US. Application Data [62] Division of Ser. No. 808,803, March 20, 1969, Pat.

[52] US Cl 424/12, 34/92; 424/3, 424/11, 424/13, 424/101 [51] Int. Cl...... F26b 5/06, GOln 1/00, GOln 33/16 [58] Field of Search ..424/3,11,12,13,101; 264/13, 14; 34/92; 62/66 [56] References Cited UNITED STATES PATENTS 3,236,732 2/1966 Arquilla 424/12 3,344,617 10/1967 Rinfret 264/14 3,548.051 12/1970 Dingwall 424/12 1 Jan. 21, 1975 5/1971 Crane 424/12 4/1972 Schuurs ..424/12 OTHER PUBLICATIONS Primary ExaminerAlbert T. Meyers Assistant Examiner-A. P. Fagelson Attorney, Agent, or FirmHugo E. Weisberger [57] ABSTRACT Pelletized analytical and immunological reagents are prepared in a stable accurate form containing predetermined and pretested measured amounts of sub-' stances capable of participating in analytical and immunological reactions, such as pregnancy tests, by forming these reagents into frozen and freeze-dried beads or spheres; a set of these pellets comprising an antiserum and an antigen is placed in a test vessel and moistened with the liquid to be tested and then allowed to stand until agglutination or precipitin reaction does or does not occur.

2 Claims, 2 Drawing Figures PELLETIZED PREGNANCY TEST REAGENTS CROSS-REFERENCE TO RELATED APPLICATION This application is a division of application Ser. No. 808,803, filed 3/20/69, now US. Pat. No. 3,655,838, issued Apr. ll, 1972.

BACKGROUND OF THE INVENTION The present invention relates to novel pelletized reagents, test methods, and apparatus for performing invitro analytical and immunological reactions, and particularly diagnostic tests therewith.

The analytical and immunological tests with which the present invention 'is concerned are most commonly laboratory tests which have as their objective the determination of the presence or absence of antigens or antibodies or enzymes in body fluids as an aid in the diagnosis of certain physiological or pathological conditions in humans and animals-Depending upon the particular combination of reagents and test liquid employed, the reaction may result in the formation of a precipitate in which case it is known as a precipitin reaction. Where the reaction is between substances distributed in a liquid medium, at least one of which substances is a solid which becomes agglomerated, the reaction is known as an agglutination reaction. The formation of the precipitate, or the agglutination or inhibition of agglutination of specially-treated particles is manifested visually in the way the precipitate forms or the particles arrange themselvesfollowing reaction.

The immunologicaltests, which may include, for example, tests for blood group type, pregnancy, and similar phenomena, are customarily performed with reagents such as, for example, a suspension of sensitized erythrocytes, and a solution of suitable antiserum, dispensed into a test vial from a dropper. Even though the suspension of erythrocytes may have been titered very carefully the use of vials and droppers is not only expensive, but is likely to result in questionable findings because of the limitations in the accuracy of ordinary droppers. Such droppers are usually uncalibrated, and although the accuracy of the drop'size is of great importance, such accuracy is rarely attained and the size of the drops is variable and undependable.

In view of the shortcomings of the vial-dropper test methods, it has been proposed in the prior art to carry out agglutination reactions by depositing an accurately measured drop of a reagent onto a slide or cardboard supporting surface and allowing the drop to be dried, whereupon the test liquid can subsequently be deposited thereon to observe the results. Methods of this type are also subject to inaccuracies in the application of the reagents as well as the observations made.

It is also frequently necessary for immunological reagents, such as sensitized erythrocytes, or sensitive protein materials, to be preserved by refrigeration. This necessarily involves the presence of special refrigeration equipment and is space-consuming and 'also timeconsuming because of the problem of transferring refrigerated solutions. Efforts have been made to overcome the limitations of the vial-dropper test methods, and the slide type methods, by subjecting reagents, which may be incompatible with each other in the presence of moisture, to freezing in successive layers in a container and thereafter freeze-drying the frozen strata, and a method of this type is described in US.

Pat. No. 3,269,905 However, such a procedure requires special apparatus and technical knowledge and is expensive and time-consuming to carry out.

GENERAL DESCRIPTION OF THE INVENTION A principal object of the present invention is to provide in a single container, all the necessary analytical reagents for diagnostic tests of the types previously described in a pelletized form in which they are stable, ac-

curate in unit content, and completely non-reactive until they are contacted by the liquid to be tested. Another object of the invention is to provide a method for the manufacture of pelletized analytical, immunological, or diagnostic reagents which is inexpensive and practical and which doesv not require special elaborate equipment but which may be carried out conveniently for commercial purposes on a large scale. Still another object is to make the reagents for diagnostic tests available in a convenient form while at the same time insuring the accuracy of the amounts of reagents present to provide dependable test resultsQStill another object is to provide a method that permits two or more otherwise incompatible substances to be freeze-dried in a single container, while avoiding premature reaction which might come about in the presence of moisture. A further objective is to provide a person performing a diagnostic test with a simple container device in which the reagents are present in pelletized form so that the test results can be visually observed.

PELLETIZ-ED REAGENTS In accordance with a first aspect of the present invention, there are provided novel dry solid stable pelletized analytical, diagnostic, and immunological reagents in the form of beads or small spheres, each furnishing a predetermined and accurately measured quantity of the reagent. Even though the reagents from which the pellets are prepared are reactive and may even be mutually incompatible, the pellets themselves have the advantage that they are stable and may be present together in a common container for an indefinite period of time without interaction. However, the reagents in the pellets are readily reconstituted and made ready for an analytical, immunological or diagnostic test by the simple addition thereto of the liquid to be tested.

The composition, preparation and use of the pelletized reagents of the invention will be specifically illustr'ated with respect to reagents for an immunological or diagnostic test for detecting the presence of human chorionic gonadotropic (HCG) in urine, which test is utilized in the diagnosis of pregnancy.

However, it will be readily understood by those skilled in this art that the principles of the invention are not to be regarded as limited thereto, but may be extended to the preparation and use of a wide range of pelletized analytical, immunological, and diagnostic reagents, and to a wide variety of tests which may employ one or a multiplicity of different pelletized reagents. Furthermore, auxiliary substances, such as buffers, may also be pelletized in accordance with the invention and may be utilized in dry stable form in conjunction with one or more diagnostic test reagent pellets.

The process of preparation of the pelletized reagents of the invention broadly comprises the steps of:

a. forming an aqueous solution or suspension of the reagent having a predetermined concentration;

b. forming an accurately measured or calibrated,

free-falling drop of said solution or suspension;

c. allowing said drop to fall through a body of a water-immiscible liquid having a density less than that of water and having a temperature gradient ranging from approximately ambient at its upper surface to at most a temperature below the freezing point of the solution being frozen at the lower portion of the column, thereby freezing said drops to frozen pellets or beads; and

d. collecting the frozen pellets containing a predetermined quantity of the reagent at the bottom of said body of liquid. The pellets may then be dried by any suitable method, but freeze-drying is preferred.

The method of preparation of the pellets of the invention will be better understood by reference to the accompanying drawings, in which FIG. 1 depicts in diagrammatic form a system for the formation of drops of reagent and the freezing thereof to solid stable pellets.

Referring to FIG. 1, an aqueous solution or suspension containing a known concentration of the reagent is first prepared. Advantageously there is'incorporated into the solution or suspension a suitable quantity of an inert matrix-producing substance or bulking agent, which aids in giving body to the freezedried pellet. Examples of suitable bulking agents include sugars, such as sucrose, mannose, lactose and mannitol, proteinaceous materials, such as serum protein, lactalbumin hydrolysate, and casein hydrolysate.

The reagent solution or suspension is pumped from its storage vessel 1 through a flexible conduit 2, which may be made of plastic, for example, transparent polyethylene tubing, by means of a proportioning pump 3. This is preferably a pulsating type pump which compresses the flexible tubing by means of rollers, thereby measuring a predetermined amount of solution per unit time. To form accurate drops, a pump which delivers about 2.0 ml per minute is used. From the pump 3 the solution flows through a pulse suppressor 4 so that a nearly uniform flow is maintained. Thence the solution passes to a special type of dropping pipet 5 which discharges a predetermined, accurately measured amount in the form of a drop. Such a drop may contain, for example. from about 0.025 to about 0.07 ml. For HCG antiserum and antigen solutions precisely 0.05 ml is chosen. since this provides frozen pellets of suitable size for testing purposes.

The pipette 5 is positioned at a suitable height above the surface of a body of water-immiscible liquid 6 which is held in a container 7, and in which the drop is frozen. The pipet is at such a height above the level of the water-immiscible liquid that splashing is prevented while at the same time the height allows for a free fall of the drop which results in proper drop size and formation of true spherical shape, either before or after entry into the water-immiscible liquid. In order to maintain the height from which the drop falls to prevent drop distortion and splash, a suction tube 8 is placed at an appropriate level. As the hexane is displaced by the aqueous volume introduced as drops this suction line pulls off excess hexane and thereby maintains a constant level.

The water-immiscible liquid used for freezing may be a liquid hydrocarbon or a liquid halogenated hydrocarbon, or mixtures thereof. Examples of suitable liquids include hexane, carbon disulfide, chloroform, heptane, iso-octane, or toluene, as well as mixtures such as hexane-chloroform or benzene-hexane. These mixtures are designed so that they will always have a density less than water. For example, hexane has a specific gravity of 0.6593 at /4C. The specific gravity can be ad- 5 justed to any desired level by blending with the hexane another liquid such as carbon tetrachloride, in order to maintain a controlled rate of fall of the drop. The rate of fall is advantageously of the order of about 1 foot per 2 seconds, depending upon the length of the liquid column. The longer the column, the faster the rate of fall which can be maintained.

The body of freezing liquid is maintained with a temperature gradient which ranges from near ambient at its upper surface and diminishes in the direction of the bottom of the liquid in such a manner that the temperature drops to about C. in the bottom portion. Advantageously the liquid is maintained for a short distance below its upper surface at a temperature between about 0 and 20C. Below this level the cooling of the liquid is arranged in such a manner that the temperature drops to 70C. in the bottom portion. However, any lower temperature than this figure can also be utilized, depending upon the nature of the liquid and the reagent being treated. For example, cryogenic liquids such as liquid nitrogen which has a boiling point of -143C., or liquid oxygen which has a boiling point of 183C., may also be employed.

The desired temperature of the liquid column is achieved either by use of a freezing mixture which sur rounds the body of liquid or by mechanical refrigeration to equivalent temperatures. For example, the freezing mixture may be a combination of dry ice and acetone, or of dry ice and methyl Cellosolve (diethylene glycol monomethyl ether).

Advantageously the upper level of the refrigerated portion of the liquid, which is maintained between about 0C. and 20C., comprises a zone extending not more than about 6 inches below the surface of the liquid. This provides a 6 inch fall at a temperature above freezing and thus an opportunity for formation of a truly spherical pellet.

In this way spherical drops are formed which freeze into beads as they descend through the liquid column. The frozen beads collect on the bottom and can be removed and freeze-dried to produce stable dry spheres containing accurately measured quantities of desired reagents. The frozen spheres are preferably collected in a wire mesh basket and may be readily handled mechanically so that they may be placed into any pre chilled container, such as a test tube, and freeze-dried in situ. Advantageously the frozen spheres are stored under refrigeration at temperatures of 50C. or lower to prevent crystal growth within the spheres, which might cause them to become friable.

For purposes of freeze-drying, one or more spheres of selected reagents are placed in a prechilled container and transferred without warming to the prechilled shelves of a conventional freeze-drying apparatus in which the drying takes place, for example, at a starting temperature of 50C. and rising during the drying to +37C. at the finish and at a pressure not higher than about p. at the start and approaching Su at the finish which is 18 hours to 24 hours later.

Where the reagent pellets are placed into a suitable test tube for future use the test tube may then be capped utilizing a moisture-proof closure and stored for an indefinite period. A testing device of this kind'is shown in FIG. 2 of the drawings.

' As will be apparent from the drawings, the test device comprises a tubular container having a transparent sidewall and bottom portion adapted to receive the liquid to be tested and provided with a moisture-proof closure. There is placed in the container at least one reagent pellet prepared in accordance with the invention. The liquid tobe tested is applied to the pellet or pellets by opening the closure and introducing a measured amount of the liquid by means of a dropper.

It is apparent that the principles of the invention can be applied not only to the preparation of analytical reagents but also to the preparation of pharmaceutical dosage forms, particularly those involving'small dosages of the medicament involved.

In the field of immunology by the selection of appropriate reagents, the test pellets can be used for performing any immunological test in which two incompatible test reagents are present in the same tube, such as, for example, the pregnancy test described more fully below, and also test for blood group substances in plasma and serum, blood group typing, and antigens and antibodies of various kinds, including rheumatoid factor. syphilis antigen, antistreptolysin O, infectious mononucleosis, and other agglutination or precipitin tests. Moreover, in order to demonstrate to a'user of the test device what a proposed reaction looks like, or as a control, a pellet of the substance being tested for can be treated in a separate test alongside the actual specimen to be tested, using two tubes, e.g., a freezedried pellet of known pregnant urine.

DESCRIPTION OF THE PREFERRED EMBODIMENTS The following examples are indicative of a presently preferred embodiment of the invention but are not to be considered as limiting the invention thereto.

The preparation of a set of test reagent pellets for the detection of human chorionic gonadotropin in urine is disclosed in the following examples:

EXAMPLE 1 Preparation of l-ICG Antiserum Pellets The reagents are Sucrose 10.2 Gm.

Sodium Chloride 0.765 Gm.

Dihusic Sodium Phosphate Heptahydrate 2.462 Gm.

(Na HPO 7H O) Monohasic Potassium Phosphate 0.489 Gm.

(KH- ,PO

Distilled water. q.s. 17(5) .0 ml.

Anti-human chorionic gonadotropin q.s. to yield sensitivity factor of 650 800 LU. HCG/liter and 5. 5. 3-l. 2-0 reactions with urine at 0. $00. 750. and 1000 I.U./liter urine, respectively. A reaction graded 5 is complete agglutination and is complete inhibition.

EXAMPLE 2 Preparationof Pellets of Sensitized Erythrocytes A suspension of sheep erythrocytes is treated in conventional manner with formalin and tannin and centrifuged and washedwith a phosphate sodium chloride buffer of pH 6.4 and then incorporated in this buffer. To this mixture there is added an equal volume of a solution of 501.U. HCG per ml. in a buffer of pH 6.4. The mixture is stored for 48 hours at 37C., whereupon formaldehyde is added until final concentration is obtained of 0.25% (wt/vol) formaldehyde. Next this mixture is stored for 15 hours at 37C., whereupon the erythrocytes are again centrifuged, washed with physiological salt solution, incorporated as 10% v/v suspension in a physiological salt solution containing 0.1% of bovine serumalbumin and stored until needed at 0- 4C. Thereafter the erythrocytes are centrifuged,

washed with physiological salt solution and freezedried in conventional-manner. Alternatively the formolized tanned cells are washed and suspended in a phosphate sodium chloride buffer at pH 7.6. To this mixture is added an equal volume of a solution of 50 I.U. I-ICG/ml. This mixture is maintained at 56C. for 18 hours, then washed and resuspended in 0.9% sodium chloride and mixed equal parts with a solution of formaldehyde (1.5%) in 0.9% saline. This mixture is stored at 2 -8C. for about 1 week whereupon the erythrocytes are again washed with 0.9% sodium chloride and finally suspended to a concentration of 6.6% in a mixture of pH 712 phosphate buffer containing sucrose 6% and bovine serumalbumin 1.5%. This mixture is freeze-dried and held dry until needed. The sheep erythrocytes which have thus been sensitized by chemically affixing HCG to their surfaces are suspended in a mixture of bufferand a diluent such as sucrose and bovine serumalbumin, so that there is contained in each 0.05 ml the precise optimal quantity for a single HCG test.

Erythrocyte pellets are produced by reconstituting the previously freeze-dried, sensitized erythrocytes to five-sixths of the original volume, i.e., 12 ml of freezedried 6.67% suspension in final suspension medium are reconstituted with 10 ml of distilled water. This suspension is pumped to a microtiter dropping pipet. Fine bore polyethylene tubing (ID. 0.023 inch) is used to minimize erythrocytes settling and the pump is not turned off during the process except momentarily.

The suspension is converted into calibrated drops aspreviously described which are allowed to fall through a column of hexane cooled by a mixture of dry icemethyl Cellosolve, the temperature of the hexane ranging from about ambient at its upper surface to -C. near the bottom of the column. The pellets are col- Ec te d and stored as in Example 1. I

EXAMPLE 3 Preparation of Buffer Pellets The reagents are:

The above salts are dissolved in about 150 ml of water. The solution is adjusted to pH 7.2 with 5.0 N NaOH, then q.s. with water to 170 ml. Then add 0.2 ml of a stock dye solution consisting of a 1.0 mg/ml solution (store dye solution in the refrigerator). This solution need not be refrigerated during the production of the pellets.

The buffer pellets are produced in an identical manner to that described for the antiserum pellets. Subsequent to production, the handling and storage are the same.

EXAMPLE 4 Method of Performing Pregnancy Test One of each of the antiserum, HCG sensitized erythrocytes, and buffer pellets are placed in the bottom of the test vial shown in FIG. 2 of the drawings. There is introduced into the test vial by means of a dropper a sample of the urine to be tested and thereafter an additional volume of water is introduced equal to about four times the amount of urine added. The test vial is then recapped and shaken up and down for 30 seconds. after which it is allowed to stand undisturbed for a period of 2 hours. The bottom of the vial is visually inspected for a positive or negative indication of agglutination. The formation of a donut-shaped ring is a positive indication of pregnancy.

Pyruvic acid NADH '2, L-lactic acid NAD In the foregoing equations, the abbreviations mean:

G.P.T. glutamate-pyruvate transaminase NADH nicotinamide-adenine-dinucleotide, re-

duced form NAD nicotinamide-adenine-dinucleotide, oxidized form LDH lactic acid dehydrogenase For each molecule pyruvic acid originating from reaction (I), one molecule of NADH is oxidized to NAD. The decrease in optical density is determined directly in U. V. at 334 nm in a 25C. photometer cuvette.

a. Preparation of buffer-enzyme pellets The following reagents solutions are prepared:

Solution 1: 250 ml 3 millimolar aqueous solution of reduced nicotinamide-adenine-dinucleotide. The fresh solution is kept at 0 4C. until needed.

Solution 2: 500 ml aqueous solution of lactic acid dehydrogenase, having at least 180,000 I.U. LDH-activity per litre. The fresh solution is kept at 0 4C. until needed. I

Solution 3: 1250 ml 0.2 molar aqueous solution of L- alanine.

Solution solutions 4: 3000 ml of an aqueous solution which is 5 millimolar in ethylenediamine .tetraacetic acid and 50- millimolar in triethanolamine. The pH of this solution has been adjusted to a pH of 7.5.

The soutions 3 and 4 are thoroughly mixed and cooled to 0 4C. Then the solutions I and 2 are added and the solution is thoroughly stirred.

Buffer-enzyme pellets are prepared from the foregoing mixture as described in Example I. They are filled into small polyethylene vials as shown in FIG. 2, each vial containing that number of pellets corresponding with 0.5 ml of the buffered solution.

After lyophilization the vials are closed with a red screw cap.

b. Preparation of buffer-substrate pellets The following reagent solutions are prepared:

Solution 5: 200 ml 0.2 molar aqueous sodium-a-keto glutarate. The fresh solution is kept at 0 4C. until needed.

Solution 6: 800 ml of an aqueous solution having the composition of solution 4.

Solution 6 is cooled to 0 4C. and then thoroughly mixed with solution 5.

Buffer-substrate pellets of 0.1 ml of this mixed solution are prepared according to Example I. They are filled into small polyethylene vials as shown in FIG. 2, each vial containing one pellet. After lyophilization the vials are closed with blue screw caps.

c. Performance of the kinetic U.V.-assay To a vial prepared as described in this example under (a), 0.5 ml of distilled water and 0.2 ml of the serum to be assayed are added using Marburg pipettes. After shaking, the resulting solution is brought quantitatively into a 25C. cuvette of an Eppendorf spectrophotometer. Pre-incubation takes place for about 10 minutes. During this time the endogenous substrate in the sample is being converted. Optical density is read until constant. Then a blue'capped vial is opened and 0.1 ml distilled water is added with a Marburg pipette. The clear solution is then brought quantitatively into the euvette and thoroughly mixed.

Optical density readings are made then every 30 seconds, and the decrease is noted for at least 2 minutes. The values obtained are averaged, and the S.G.P.T. activity of the sample is calculated using the formula:

I.U. A O.D./min X 667 p. Mole X min" litre".

What is claimed is: l. A pregnancy test reagent adapted for detecting the presence of human chorionic gonadotropin in urine consisting essentially of astable frozen and freeze-dried pellet containing a predetermined immunologically effective amount for test purposes of human chorionic gonadotropin antiserum together, with an effective amount of a phosphate buffer.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US3236732 *Jan 22, 1962Feb 22, 1966Edward R ArquillaPregnancy test method and immunological indicator therefor
US3344617 *Mar 18, 1966Oct 3, 1967Union Carbide CorpApparatus for the preservation of biological substances
US3548051 *Mar 17, 1967Dec 15, 1970OrganonPreparation of erythrocytes for immunochemical determination of human chorionic gonadotropin
US3579306 *Jan 22, 1969May 18, 1971OrganonDiagnostic test device
US3654090 *Sep 24, 1968Jul 20, 1982 Title not available
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3995019 *Mar 4, 1975Nov 30, 1976Baxter Travenol Laboratories, Inc.Diagnostic reagent system
US4003988 *Jun 1, 1976Jan 18, 1977Warner-Lambert CompanyDirect agglutination test for pregnancy
US4184849 *Dec 5, 1977Jan 22, 1980Technicon Instruments CorporationMixed agglutination
US4282002 *Sep 6, 1979Aug 4, 1981Akzona IncorporatedSensitized sheep stroma immunoassay for rheumatoid factor
US4295280 *Mar 17, 1980Oct 20, 1981American Home Products CorporationMethod of obtaining a lyophilized product
US4308026 *Jul 23, 1979Dec 29, 1981Mochida Seiyaku Kabushiki KaishaAgglutination inhibition immunoassay for hapten using two differently sensitized particles
US4320111 *Mar 6, 1980Mar 16, 1982American Home Products CorporationImmunologic compositions methods of preparation and use
US4351158 *Jan 22, 1980Sep 28, 1982American Home Products CorporationMethod of producing multicomponent lyophilized product
US4447527 *Feb 22, 1982May 8, 1984Syva CompanySingle test formulations for enzyme immunoassays and method for preparation
US4587222 *Jul 1, 1982May 6, 1986Laboratories PolypharmaReagent comprising treated red blood cells and methods for detecting rheumatoid factor
US4712310 *Sep 15, 1986Dec 15, 1987E. I. Du Pont De Nemours And CompanyCo-spray technique
US4780285 *Aug 5, 1986Oct 25, 1988Akzo N.V.Device for the carrying out of an immunochemical determination
US4988627 *Dec 18, 1987Jan 29, 1991Eastman Kodak CompanyTest device with dried reagent drops on inclined wall
US6165796 *Nov 26, 1997Dec 26, 2000Beckman Coulter, Inc.Pipettable ion detector and method
US6251684Apr 24, 1998Jun 26, 2001Abaxis, Inc.Dried chemical compositions
US7767447Dec 12, 2008Aug 3, 2010Gen-Probe IncorporatedInstruments and methods for exposing a receptacle to multiple thermal zones
US7780336Dec 12, 2008Aug 24, 2010Gen-Probe IncorporatedInstruments and methods for mixing the contents of a detection chamber
US8048375Dec 12, 2008Nov 1, 2011Gen-Probe IncorporatedGravity-assisted mixing methods
US8052929Apr 1, 2011Nov 8, 2011Gen-Probe IncorporatedGravity-assisted mixing methods
US8480976Jul 13, 2011Jul 9, 2013Gen-Probe IncorporatedInstruments and methods for mixing the contents of a detection chamber
US8491178Mar 7, 2012Jul 23, 2013Gen-Probe IncorporatedInstruments and methods for mixing the contents of a detection chamber
US8669110 *Mar 20, 2009Mar 11, 2014Prabhjyot DehalUses of reagents in sample collection and cartridge systems
US8735055Dec 12, 2008May 27, 2014Gen-Probe IncorporatedMethods of concentrating an analyte
US8765367Dec 12, 2008Jul 1, 2014Gen-Probe IncorporatedMethods and instruments for processing a sample in a multi-chambered receptacle
US8769841Sep 24, 2012Jul 8, 2014Octapharma AgLyophilisation targeting defined residual moisture by limited desorption energy levels
US8784745Jun 24, 2013Jul 22, 2014Gen-Probe IncorporatedMethods for manipulating liquid substances in multi-chambered receptacles
US8828654Jul 8, 2011Sep 9, 2014Gen-Probe IncorporatedMethods for manipulating liquid substances in multi-chambered receptacles
US9744506Apr 3, 2013Aug 29, 2017Gen-Probe IncorporatedInstruments for mixing the contents of a detection chamber
US20080172902 *Jun 19, 2007Jul 24, 2008Octapharma AgLyophilisation targeting defined residual moisture by limited desorption energy levels
US20090107000 *Feb 1, 2005Apr 30, 2009Georg-Wilhelm OetjenMethod and Device for Freeze-Drying Products
US20090136913 *Dec 12, 2008May 28, 2009Gen-Probe IncorporatedGravity-Assisted Mixing Methods
US20090137029 *Dec 12, 2008May 28, 2009Gen-Probe IncorporatedMulti-Chambered Receptacles
US20090142745 *Dec 12, 2008Jun 4, 2009Gen-Probe IncorporatedInstruments and methods for exposing a receptacle to multiple thermal zones
US20110059547 *Mar 20, 2009Mar 10, 2011Iti Scotland LimitedUses of reagents in sample collection and cartridge systems
US20110189661 *Apr 1, 2011Aug 4, 2011Gen-Probe IncorporatedGravity-assisted mixing methods
EP0641389A1Aug 12, 1992Mar 8, 1995Abaxis, Inc.Reagent compositions for analytical testing
EP0641389B2Aug 12, 1992Aug 22, 2007Abaxis, Inc.Reagent compositions for analytical testing
EP2191897A1Jun 20, 2008Jun 2, 2010Gen-Probe IncorporatedInstrument and receptacles for performing processes
EP2425894A1Jun 20, 2008Mar 7, 2012Gen-Probe IncorporatedInstruments and method for exposing a receptacle to multiple thermal zones
EP2465609A1Jun 20, 2008Jun 20, 2012Gen-Probe IncorporatedInstruments and method for mixing the contents of a detection chamber
WO1989006976A1 *Feb 1, 1989Aug 10, 1989Quadrant Bioresources LimitedMethod of drying macromolecules
WO2009115608A2 *Mar 20, 2009Sep 24, 2009Iti Scotland LimitedUses of reagents in sample collection and cartridge systems
WO2009115608A3 *Mar 20, 2009Dec 3, 2009Iti Scotland LimitedUses of reagents in sample collection and cartridge systems
WO2010088496A1Jan 29, 2010Aug 5, 2010Gen-Probe IncorporatedSystems and methods for detecting a signal and applying thermal energy to a signal transmission element
U.S. Classification436/521, 422/920, 436/805, 436/810, 436/826, 436/814, 34/92, 436/818, 424/533
International ClassificationG01N33/76, G01N33/543, B01J2/06, F25C1/00, B01L3/02
Cooperative ClassificationY10S436/818, Y10S436/814, F25C1/00, Y10S436/826, Y10S435/963, Y10S436/805, G01N33/76, B01L3/0203, Y10S436/81, B01J2/06
European ClassificationB01L3/02B, B01J2/06, G01N33/76, F25C1/00